Nathan B Fountain|John M Freeman - JoVE Visualize

Showing results (31-40 of 88) with videos related to

Pageof 9

Sort By:

Epilepsy & Behavior Reports|October 17, 2024

Developing optimized physical activity interventions for drug-resistant epilepsy: Challenges and lessons learned from a remote exercise intervention pilot trialHalley B Alexander, Heidi M Munger Clary, Hossam A Shaltout, et al.

Epilepsy & Behavior : E&B|November 11, 2023

A single-center survey on physical activity barriers, behaviors and preferences in adults with epilepsyHalley B Alexander, Madison Arnel, Nathaniel O'Connell, et al.

Epilepsy & Behavior : E&B|March 1, 2003

Changing Physician Attitudes Toward the Ketogenic Diet: A "Parent-Centered" Approach to Physician Education about a Medication AlternativeCheryl Hemingway, Paula L. Pyzik, John M. Freeman

Epilepsy & Behavior : E&B|October 7, 2003

Landau-Kleffner syndrome responsive to levetiracetamEric H Kossoff, Dana Boatman, John M Freeman

Neurology|December 11, 2002

Outcomes of 32 hemispherectomies for Sturge-Weber syndrome worldwideEric H Kossoff, Carol Buck, John M Freeman

CNS Drugs|November 25, 2010

Examining the clinical utility of lacosamide: pooled analyses of three phase II/III clinical trialsSteve Chung, Elinor Ben-Menachem, Michael R Sperling, et al.

Epilepsy & Behavior : E&B|May 16, 2023

Multifocal hypometabolic correlates to deficits of verbal memory in mesial temporal lobe epilepsyRacheal M Smetana, Prem P Batchala, Bern G Lee, et al.

Epilepsia|April 21, 2015

Interrater reliability in interpretation of electrocorticographic seizure detections of the responsive neurostimulatorMark Quigg, Felice Sun, Nathan B Fountain, et al.

Epilepsia|April 19, 2023

Time-to-event clinical trial designs: Existing evidence and remaining concernsWesley T Kerr, Stéphane Auvin, Serge Van der Geyten, et al.

Epilepsy Research|February 3, 2007

Prospective assessment of levetiracetam pharmacokinetics during dose escalation in 4- to 12-year-old children with partial-onset seizures on concomitant carbamazepine or valproateNathan B Fountain, Joan A Conry, Ildefonso Rodríguez-Leyva, et al.

Pageof 9

Showing results (31-40 of 88) with videos related to

Sort By:

Pageof 9

Epilepsy & Behavior Reports|October 17, 2024

Developing optimized physical activity interventions for drug-resistant epilepsy: Challenges and lessons learned from a remote exercise intervention pilot trialHalley B Alexander, Heidi M Munger Clary, Hossam A Shaltout, et al.

Epilepsy & Behavior : E&B|November 11, 2023

A single-center survey on physical activity barriers, behaviors and preferences in adults with epilepsyHalley B Alexander, Madison Arnel, Nathaniel O'Connell, et al.

Epilepsy & Behavior : E&B|March 1, 2003

Changing Physician Attitudes Toward the Ketogenic Diet: A "Parent-Centered" Approach to Physician Education about a Medication AlternativeCheryl Hemingway, Paula L. Pyzik, John M. Freeman

Epilepsy & Behavior : E&B|October 7, 2003

Landau-Kleffner syndrome responsive to levetiracetamEric H Kossoff, Dana Boatman, John M Freeman

Neurology|December 11, 2002

Outcomes of 32 hemispherectomies for Sturge-Weber syndrome worldwideEric H Kossoff, Carol Buck, John M Freeman

CNS Drugs|November 25, 2010

Examining the clinical utility of lacosamide: pooled analyses of three phase II/III clinical trialsSteve Chung, Elinor Ben-Menachem, Michael R Sperling, et al.

Epilepsy & Behavior : E&B|May 16, 2023

Multifocal hypometabolic correlates to deficits of verbal memory in mesial temporal lobe epilepsyRacheal M Smetana, Prem P Batchala, Bern G Lee, et al.

Epilepsia|April 21, 2015

Interrater reliability in interpretation of electrocorticographic seizure detections of the responsive neurostimulatorMark Quigg, Felice Sun, Nathan B Fountain, et al.

Epilepsia|April 19, 2023

Time-to-event clinical trial designs: Existing evidence and remaining concernsWesley T Kerr, Stéphane Auvin, Serge Van der Geyten, et al.

Epilepsy Research|February 3, 2007

Prospective assessment of levetiracetam pharmacokinetics during dose escalation in 4- to 12-year-old children with partial-onset seizures on concomitant carbamazepine or valproateNathan B Fountain, Joan A Conry, Ildefonso Rodríguez-Leyva, et al.

Pageof 9